RAYMOND JAMES TRUST N.A. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES TRUST N.A. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2021$194,000
-8.1%
11,525
+0.1%
0.01%
-14.3%
Q1 2021$211,000
-52.3%
11,516
-52.5%
0.01%
-58.8%
Q4 2020$442,000
-0.5%
24,246
-2.5%
0.02%
-10.5%
Q3 2020$444,000
+6.5%
24,863
+6.7%
0.02%
-5.0%
Q2 2020$417,000
+16.2%
23,295
-1.5%
0.02%
-4.8%
Q1 2020$359,000
-10.0%
23,660
+16.8%
0.02%
+10.5%
Q4 2019$399,000
+20.5%
20,252
+5.2%
0.02%
+11.8%
Q3 2019$331,000
+31.9%
19,246
+36.1%
0.02%
+21.4%
Q2 2019$251,000
+13.1%
14,140
+29.4%
0.01%
+7.7%
Q1 2019$222,00010,9270.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders